Nanobiotix S.A.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Company is selling new shares to raise cash for operations, which dilutes existing shareholders but provides funding.
Company plans to sell shares in US and Europe to raise capital; details matter because it affects how many shares exist.
Stocky reads Nanobiotix S.A.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Nanobiotix S.A.'s most recent tracked filing was a 424B5 on 22 May 2026: Raises €85 million through share and warrant offering.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.